Kymera Therapeutics, Inc. (KYMR)

Kymera Therapeutics Statistics

Total Valuation

KYMR has a market cap or net worth of $4.29 billion. The enterprise value is $3.41 billion.

Market Cap	4.29B
Enterprise Value	3.41B

Important Dates

The next confirmed earnings date is Tuesday, November 4, 2025, before market open.

Earnings Date	Nov 4, 2025
Ex-Dividend Date	n/a

Share Statistics

KYMR has 71.50 million shares outstanding. The number of shares has increased by 21.55% in one year.

Current Share Class	71.50M
Shares Outstanding	71.50M
Shares Change (YoY)	+21.55%
Shares Change (QoQ)	+0.38%
Owned by Insiders (%)	1.29%
Owned by Institutions (%)	78.14%
Float	46.97M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	106.39
Forward PS	74.72
PB Ratio	4.36
P/TBV Ratio	4.42
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	76.37
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 8.32, with a Debt / Equity ratio of 0.09.

Current Ratio	8.32
Quick Ratio	8.06
Debt / Equity	0.09
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-996.36

Financial Efficiency

Return on equity (ROE) is -33.26% and return on invested capital (ROIC) is -21.30%.

Return on Equity (ROE)	-33.26%
Return on Assets (ROA)	-19.92%
Return on Invested Capital (ROIC)	-21.30%
Return on Capital Employed (ROCE)	-29.89%
Revenue Per Employee	$237,824
Profits Per Employee	-$1.47M
Employee Count	188
Asset Turnover	0.05
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +22.39% in the last 52 weeks. The beta is 2.27, so KYMR's price volatility has been higher than the market average.

Beta (5Y)	2.27
52-Week Price Change	+22.39%
50-Day Moving Average	51.71
200-Day Moving Average	40.79
Relative Strength Index (RSI)	57.67
Average Volume (20 Days)	622,617

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, KYMR had revenue of $44.71 million and -$275.43 million in losses. Loss per share was -$3.48.

Revenue	44.71M
Gross Profit	-246.16M
Operating Income	-311.86M
Pretax Income	-275.43M
Net Income	-275.43M
EBITDA	-305.06M
EBIT	-311.86M
Loss Per Share	-$3.48

Balance Sheet

The company has $665.45 million in cash and $85.71 million in debt, giving a net cash position of $877.36 million or $12.27 per share.

Cash & Cash Equivalents	665.45M
Total Debt	85.71M
Net Cash	877.36M
Net Cash Per Share	$12.27
Equity (Book Value)	971.48M
Book Value Per Share	13.77
Working Capital	640.79M

Cash Flow

In the last 12 months, operating cash flow was -$251.01 million and capital expenditures -$1.91 million, giving a free cash flow of -$252.92 million.

Operating Cash Flow	-251.01M
Capital Expenditures	-1.91M
Free Cash Flow	-252.92M
FCF Per Share	-$3.54

Margins

Gross Margin	n/a
Operating Margin	-697.51%
Pretax Margin	-616.03%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

KYMR does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-21.55%
Shareholder Yield	-21.55%
Earnings Yield	-6.42%
FCF Yield	-5.89%

Analyst Forecast

The average price target for KYMR is $65.56, which is 9.21% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$65.56
Price Target Difference	9.21%
Analyst Consensus	Strong Buy
Analyst Count	18
Revenue Growth Forecast (5Y)	7.98%
EPS Growth Forecast (5Y)	7.94%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

KYMR has an Altman Z-Score of 8.39 and a Piotroski F-Score of 1.

Altman Z-Score	8.39
Piotroski F-Score	1